MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., provider of the leading enterprise platform for precision health data, today announced that the DNAnexus-built UK Biobank Research Analysis Platform has been selected as the BioInformatics Solution of the Year in the fourth annual BioTech Breakthrough Awards program. The awards program is conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life science and biotechnology companies, products, and services around the globe.
The cloud-based, DNAnexus-built UK Biobank Research Analysis Platform is the only environment for approved researchers to access and analyze the latest information in the UK Biobank’s vast database, which currently includes more than 30 petabytes of de-identified health and lifestyle information and whole-genome sequencing data from 500,000 participants. It was designed to accommodate the increasing scale of the UK Biobank resource and to enable scientists to collaborate globally in a secure environment. Today, more than 30,000 approved researchers from at least 90 countries are using the data to identify genetic variants associated with diseases and drive the discovery of new diagnostics, treatments, and cures.
“The UK Biobank is the world’s most comprehensive source of broad and diverse biomedical data, and it has already led to numerous groundbreaking scientific discoveries and advancements in patient care,” said Thomas Laur, CEO at DNAnexus. “DNAnexus is grateful to be recognized by BioTech Breakthrough for our role in this project and our ongoing commitment to making precision health a reality for all.”
The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the world’s top companies, solutions, and products in the life science and biotechnology markets today. This year’s program attracted thousands of nominations from more than 14 different countries throughout the world, serving as a global recognition platform that encourages bold ideas and solutions that will shape the future of biotechnology.
“We’re thrilled to award the BioInformatics Solution of the Year award to DNAnexus,” said Bryan Vaughn, Managing Director, BioTech Breakthrough. “The DNAnexus-built UK Biobank Research Analysis Platform is a vital resource that is helping to democratize access to biomedical data and increase the speed, scale, and ease of scientific discoveries around the world.”
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
About DNAnexus
DNAnexus, the enterprise platform for precision health data, is on a mission to accelerate the development, approval, and delivery of personalized treatments. Building on more than 15 years of bioinformatics innovation and genomics expertise, DNAnexus powers a connected data ecosystem trusted by the world’s precision health leaders. This flexible ecosystem makes omics and real-world data accessible, actionable, and secure while unlocking insights that improve patient lives. For more information, visit www.dnanexus.com or follow @DNAnexus on social media.
